In the News

484 News Items found
Papillary renal cell carcinoma under the microscope
Finding
Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.
Mom and daughter having conversation
Ask the Expert
Find tools for discussing a cancer diagnosis with your children.
DNA molecules wrapped around histones
Feature
Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Joan Massagué
Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
Pictured: Joan Massagué
Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.
Scientist Gabriela Chiosis in her lab
In the Lab
Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease.
Portrait of a live zebrafish with dark patterning around and above the eyes
In the Lab
A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer.
MSK gastroenterologist Robin Mendelsohn seen smiling at desk.
Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering medical oncologist Dean Bajorin
Q&A
People with bladder cancer may soon have a new treatment option following surgery.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.